X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.00
Delayed Data
As of May 26
 -0.0301 / -1.48%
Today’s Change
1.55
Today|||52-Week Range
5.00
+1.01%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for X T L Biopharmaceuticals Ltd have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +200.01% increase from the last price of 2.00.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in X T L Biopharmaceuticals Ltd. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.00
Sales
$0.00
Reporting Date
Jun 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
 
 
Growthannually -100.00%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account